Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03414047
Title A Study of Prexasertib (LY2606368) in Platinum-Resistant or Refractory Recurrent Ovarian Cancer
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors Eli Lilly and Company

peritoneum cancer

fallopian tube cancer

ovarian serous carcinoma



Age Groups: senior | adult
Covered Countries USA | ITA | ESP | BEL

No variant requirements are available.